课题基金 / 基金详情

THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)

THE CAROTENE AND RETINOL EFFICACY TRIAL (CARET)
胡萝卜素和视黄醇功效试验 (CARET)
批准号:
7290546
负责人:
GARY E GOODMAN
金额:
$43.93万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2007-12-31

项目成果

GARY E GOODMAN的其他基金

相似基金

相关文献

期刊论文(41)
专著(0)
科研奖励(0)
会议论文
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival.
一项多摩尼克研究将TNS3和SEPT7与长期的以前吸烟NSCLC生存联系起来。
DOI: 10.1038/s41698-021-00182-3
发表时间: 2021-05-17
期刊: NPJ precision oncology
影响因子: 7.9
作者: [Shen S, Wei Y, Li Y, Duan W, Dong X, Lin L, You D, Tardon A, Chen C, Field JK, Hung RJ, Liu G, Zhu D, Amos CI, Su L, Zhao Y, Hu Z, Shen H, Zhang R, Chen F, Christiani DC]
通讯作者: Christiani DC
Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
内源性激素和前列腺癌风险:胡萝卜素和视黄醇功效试验中的病例对照研究。
DOI: --
发表时间: 2003
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
影响因子: --
作者: [Chen,Chu, Weiss,NoelS, Stanczyk,FrankZ, Lewis,SKay, DiTommaso,Dante, Etzioni,Ruth, Barnett,MattJ, Goodman,GaryE]
通讯作者: Goodman,GaryE
DOI: 10.1186/s12859-022-04568-3
发表时间: 2022-01-24
期刊: BMC bioinformatics
影响因子: 3
作者: [Rosenberger A, Tozzi V, Bickeböller H, INTEGRAL-ILCCO consortium]
通讯作者: INTEGRAL-ILCCO consortium
Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.
用于诊断前列腺癌的系列前列腺特异性抗原、游离前列腺特异性抗原与总前列腺特异性抗原的比率和复合前列腺特异性抗原。
DOI: --
发表时间: 2001
期刊: The Journal of urology
影响因子: --
作者: [Ellis,WJ, Etzioni,R, Vessella,RL, Hu,C, Goodman,GE]
通讯作者: Goodman,GE
25
    The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
    The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
    INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
    INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
    海外基金